BRIEF published on 07/28/2026 at 15:25, 1 month 30 days ago Edison Research Analyzes BB Biotech's Robust Q2 Performance Investment Strategy Portfolio Expansion Market Outlook BB Biotech Q2 2026 Results
PRESS RELEASE published on 07/28/2026 at 15:20, 1 month 30 days ago Edison issues report on BB Biotech (BION) Edison issues favorable report on BB Biotech (BION) Q226 results, highlighting NAV growth, portfolio adjustments, and revised payout policy, supporting positive outlook for biotechnology investing Biotechnology Edison Report BB Biotech Q226 Results
BRIEF published on 07/24/2026 at 07:05, 2 months 4 days ago BB Biotech AG Reports Interim Gains and Adjusts Dividend Policy Dividend Policy Investment Portfolio Interim Report BB Biotech Net Gain
BRIEF published on 07/24/2026 at 07:05, 2 months 4 days ago BB Biotech Q2 2026: Robust NAV Performance Amid Strategic Investments Portfolio Diversification Dividend Policy Strategic Investments M&A Activity Biotechnology Performance
PRESS RELEASE published on 07/24/2026 at 07:00, 2 months 4 days ago EQS-Adhoc: BB Biotech AG publishes its interim report and revises its dividend policy BB Biotech AG publishes its interim report for the first half of 2026, reporting a net gain and revising its dividend policy. Details at www.bbbiotech.ch Financial Results Investment Company Dividend Policy BB Biotech AG Interim Report
PRESS RELEASE published on 07/24/2026 at 07:00, 2 months 4 days ago BB Biotech Q2 2026: Strong NAV outperformance driven by disciplined stock selection and portfolio positioning BB Biotech AG reports strong NAV outperformance in Q2 2026, driven by disciplined stock selection and portfolio positioning, new investments, and revised dividend policy Dividend Policy BB Biotech AG Stock Selection Q2 2026 NAV Outperformance
BRIEF published on 04/24/2026 at 07:05, 5 months 4 days ago BB Biotech AG Reports Q1 2026 Interim Results Drug Development Net Loss Investment Portfolio BB Biotech Q1 2026
BRIEF published on 04/24/2026 at 07:05, 5 months 4 days ago BB Biotech Q1 2026 Achievements and Strategic Shifts Net Asset Value Portfolio Repositioning New Investments BB Biotech Performance Dividend Inclusion
PRESS RELEASE published on 04/24/2026 at 07:00, 5 months 4 days ago EQS-Adhoc: BB Biotech AG publishes its interim report BB Biotech AG publishes its interim report for the first quarter of 2026, showing a net loss of CHF 21 mn compared to CHF 241 mn in the same period of 2025 Investment Company BB Biotech AG Interim Report Results Loss
PRESS RELEASE published on 04/24/2026 at 07:00, 5 months 4 days ago BB Biotech Q1 2026: Share price outperformance, narrowing discount and active portfolio repositioning BB Biotech AG reports Q1 2026 results with share price outperformance, narrowing discount, and active portfolio repositioning. Eleven new investments made in biotech sector Share Price BB Biotech AG Investments Portfolio Repositioning Q1 2026
Published on 09/26/2026 at 01:00, 2 days 6 hours ago Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Published on 09/25/2026 at 22:15, 2 days 9 hours ago Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 2 days 13 hours ago Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 2 days 16 hours ago HM Exploration Provides Program Update for the Lewis Pilley's Project
Published on 09/28/2026 at 07:13, 11 minutes ago Cameo Resources: High-Tech Gold Hunt in the Shadow of AngloGold!
Published on 09/28/2026 at 07:05, 19 minutes ago Arcadis deepens Autodesk collaboration to accelerate AI and data-led delivery for clients
Published on 09/28/2026 at 07:00, 24 minutes ago DKSH and Grünenthal Announce New Partnership Agreement to Accelerate Access to Innovative Pain Management Solutions Across Eight Markets in Asia-Pacific
Published on 09/28/2026 at 06:45, 39 minutes ago HBM Healthcare Investments Increases Its Stake in Portfolio Company ADARx Pharmaceuticals Through IPO
Published on 09/28/2026 at 06:20, 1 hour 4 minutes ago Aurra Markets Crowned 'Best Emerging Broker' at Forex Expo Dubai 2026
Published on 09/25/2026 at 17:40, 2 days 13 hours ago Availability of the 2026 half-year financial report
Published on 09/24/2026 at 18:00, 3 days 13 hours ago GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2026
Published on 09/24/2026 at 18:00, 3 days 13 hours ago GUILLEMOT CORPORATION: 2026 CONSOLIDATED INTERIM RESULTS
Published on 09/24/2026 at 17:45, 3 days 13 hours ago Cegedim first-half 2026 results: profitability continues to improve
